Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

STXS

STRONG SELL

Stereotaxis, Inc. · Healthcare · United States · $129M · Avg Vol: $1M/d

6
StockRank
Get insider-trade alerts
Q
30
V
25
M
21
P/E (TTM)
ROE
-156.1%
D/E
0.3x
Dividend %
Loading 1Y...
PRICE (1Y)-29.3%
1.291.441.591.741.89Jun 12Jul 7Jul 27
SMA 50SMA 200
Close
$1.30
RSI (14)
11.8
52W High
$3.59
From 52W High
0.4%

SCORE BREAKDOWN

Quality
30
ROIC
-74.1%9.2
ROE
-156.1%5.4
GP/Assets
32.2%70.3
Op. Margin
-83.1%18.6
FCF/Assets
-26.4%13.5
Piotroski
239.0
Int. Cover
N/A
D/E Ratio
0.27x44.1
Current Ratio
1.56x27.4
Value
25
P/E (TTM)
N/A
EV/EBITDA
-6.7x25.0
P/FCF
N/A
P/B
8.8x12.6
P/S
4.1x47.4
Div Yield
N/A
Momentum
21
52W High %
36%12.4
RS 6M
-59%9.5
SMA 50/200
0.81x20.9
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+47%53.2
Q Growth
N/A

FUNDAMENTALS

Market Cap
$129M
P/E (Forward)
-10.2x
Gross Margin
53.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of STXS are excluded.

TickerCompanyMkt CapStockRankSignal
STXSStereotaxis, Inc.(you)$129M6STRONG SELL
MBOTMicrobot Medical Inc.$115M19STRONG SELL
KRMDKORU Medical Systems, Inc.$176M27SELL
DXRDaxor Corporation$61M44HOLD
OSUROraSure Technologies, Inc.$273M48HOLD
KMTSKestra Medical Technologies, Ltd.$1.2B23SELL
SMTISanara MedTech Inc.$234M60HOLD
PLSEPulse Biosciences, Inc.$2.1B24SELL
EMBCEmbecta Corp.$195M74BUY
ANGOAngioDynamics, Inc.$562M58HOLD

Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%

Stereotaxis, Inc. (STXS) — Stock Score Summary

Stereotaxis, Inc. (STXS) has a MoatMap StockRank of 6/100 based on Quality (30/100), Value (25/100), and Momentum (21/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price$1.30
Market Cap$129M
P/E (Forward)-10.18
Price/Book8.78
Return on Equity-156.1%
Return on Invested Capital-74.1%
Debt/Equity0.27x
Gross Margin53.9%
Operating Margin-83.1%
Revenue Growth-15.8%
Free Cash Flow$-14M

Stereotaxis, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Stereotaxis, Inc.’s (STXS) StockRank?
MoatMap’s StockRank for Stereotaxis, Inc. (STXS) is 6/100, with a Strong Sell signal. It is a composite of Quality (30), Value (25), and Momentum (21) factor ranks across MoatMap’s 20,000+ stock universe.
Does Stereotaxis, Inc. have an economic moat?
Stereotaxis, Inc. (STXS) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Stereotaxis, Inc. a buy, hold, or sell?
MoatMap’s current signal for Stereotaxis, Inc. (STXS) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Stereotaxis, Inc. in?
Stereotaxis, Inc. (STXS) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).